LS, L., WY, N., R, M., D, W., EY, W., I, Y., . . . LA, K. (2015). Conversion to aflibercept for diabetic macular edema unresponsive to ranibizumab or bevacizumab. Dove Medical Press.
Cita Chicago Style (17a ed.)LS, Lim, et al. Conversion to Aflibercept for Diabetic macular Edema Unresponsive to Ranibizumab or Bevacizumab. Dove Medical Press, 2015.
Cita MLA (8a ed.)LS, Lim, et al. Conversion to Aflibercept for Diabetic macular Edema Unresponsive to Ranibizumab or Bevacizumab. Dove Medical Press, 2015.
Precaución: Estas citas no son 100% exactas.